Emergo Survey: Regulatory Issues Remain Biggest Challenge for Most Medical Device Companies
February 27, 2017 by
EMERGO SUMMARY OF KEY POINTS:
- Regulatory issues continue to be the biggest business challenge for medical device companies of all sizes.
- Managers at smaller firms report greater concern for funding and capital issues, while largest firms are more challenged by pricing and competition pressures.
- Medium- and large-sized firms cite product development as a significant challenge, as well.
- Changing regulatory environments continue to present the biggest business challenge for a majority of medical device company senior managers, according to an annual Emergo industry survey.
Asked to identify the biggest business challenge they face as part of Emergo’s 2017 Global Medical Device Industry Outlook, nearly 70% of more than 500 senior managers of medical device companies surveyed cited changing regulatory environments as their top issue. But depending on respondents’ size, other challenges such as product development, profitability and funding were also identified.
-
Medical device regulatory challenges: still number one
Regulatory issues perennially top the list of business challenges in Emergo’s industry surveys, and this year was no different. But while 66% of senior managers identified regulatory changes generally as their biggest challenge, managers of larger firms were more likely to cite regulatory changes as their top concern.
